OTC Pharmaceuticals - Nordics | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$1.55bn in 2024. The market is expected to grow annually by 3.13% (CAGR 2024-2029).
The market's largest segment is the segment Analgesics with a market volume of US$387.50m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$55.12 are generated in 2024.
In the OTC Pharmaceuticals market, 17.9% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Nordics is experiencing significant growth and development due to various factors. Customer preferences in the Nordics region are shifting towards self-medication and convenience.

Consumers are increasingly seeking over-the-counter (OTC) pharmaceutical products to treat common ailments and minor health issues. This trend is driven by the desire for quick and easy access to healthcare solutions, as well as the growing awareness of the effectiveness and safety of OTC medications. Trends in the market indicate a strong demand for OTC pharmaceuticals in the Nordics.

The region is witnessing a rise in the availability and variety of OTC products, catering to a wide range of health needs. This includes products for pain relief, cough and cold, digestive health, and skincare. The market is also witnessing an increase in the number of private label brands, offering affordable alternatives to well-known OTC brands.

Local special circumstances in the Nordics contribute to the growth of the OTC Pharmaceuticals market. The region has a well-developed healthcare system, with easy access to pharmacies and healthcare professionals. This enables consumers to seek advice and purchase OTC medications conveniently.

Additionally, the high level of education and awareness among the population further fuels the demand for OTC pharmaceuticals. Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in the Nordics. The region has a high disposable income per capita, allowing consumers to afford OTC medications.

Moreover, the aging population in the Nordics is driving the demand for OTC products, as older individuals are more likely to experience chronic health conditions and require self-medication options. In conclusion, the OTC Pharmaceuticals market in the Nordics is experiencing growth and development due to changing customer preferences, increasing availability of OTC products, local special circumstances, and underlying macroeconomic factors. As consumers in the region continue to prioritize self-medication and convenience, the market is expected to witness further expansion in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.